3,0
12 feb 2024
Dipendente anonimo
Dipendente attuale
Malines
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
- driven and passionate team - strategic shift to cell therapy and oncology
Svantaggi
- volatile environment - many reorganisations past few years